ACTIVE SUBSTANCE / INN

HYDROFLUMETHIAZIDE

Brand name(s): SALUTENSIN-DEMI, HYDROFLUMETHIAZIDE, HYDROFLUMETHIAZIDE AND RESERPINE, SALUTENSIN, DIUCARDIN, SALURON, RESERPINE AND HYDROFLUMETHIAZIDE
FDA LISTED
DISCONTINUED
ANDA088907
NDA012359
ACTIVE SUBSTANCE
Hydroflumethiazide
REGULATORS
FDA
SPONSORS / MAH
WATSON LABS, WYETH AYERST, SHIRE
TOTAL APPLICATIONS
7
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
HYDROFLUMETHIAZIDE AND RESERPINEANDA088110WATSON LABSDiscontinued
SALUTENSINNDA012359SHIREDiscontinued
SALUTENSIN-DEMINDA012359SHIREDiscontinued
HYDROFLUMETHIAZIDEANDA088850PAR PHARMDiscontinued
RESERPINE AND HYDROFLUMETHIAZIDEANDA088907PAR PHARMDiscontinued
SALURONNDA011949SHIRE LLCDiscontinued
DIUCARDINANDA083383WYETH AYERSTDiscontinued

FULL INTELLIGENCE ON HYDROFLUMETHIAZIDE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →